Clinical trials
Active, not recruiting Phase 1 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 11 |
| 2021 | 6 |
| 2022 | 19 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 92 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Eli Lilly and Company | 6 |
| M.D. Anderson Cancer Center | 6 |
| Massachusetts General Hospital | 4 |
| Dana-Farber Cancer Institute | 3 |
| AstraZeneca | 2 |
| City of Hope Medical Center | 2 |
| Genentech, Inc. | 2 |
| Herbert Lyerly | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 92 |
| Ovarian Neoplasms | 16 |
| Triple Negative Breast Neoplasms | 15 |
| Colorectal Neoplasms | 12 |
| Neoplasm Metastasis | 12 |
| Endometrial Neoplasms | 10 |
| Pancreatic Neoplasms | 10 |
| Stomach Neoplasms | 10 |
| Lung Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 8 |
Trials
Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.